Advisors Capital Management LLC boosted its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 20.5% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,232,609 shares of the real estate investment trust's stock after acquiring an additional 380,505 shares during the quarter. Advisors Capital Management LLC owned about 0.94% of Sabra Healthcare REIT worth $39,004,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds also recently added to or reduced their stakes in the stock. State of Michigan Retirement System lifted its position in Sabra Healthcare REIT by 1.1% during the 1st quarter. State of Michigan Retirement System now owns 56,649 shares of the real estate investment trust's stock worth $990,000 after acquiring an additional 600 shares during the period. Louisiana State Employees Retirement System lifted its position in Sabra Healthcare REIT by 0.9% during the 1st quarter. Louisiana State Employees Retirement System now owns 66,300 shares of the real estate investment trust's stock worth $1,158,000 after acquiring an additional 600 shares during the period. Harbor Capital Advisors Inc. lifted its position in Sabra Healthcare REIT by 17.2% during the 1st quarter. Harbor Capital Advisors Inc. now owns 4,377 shares of the real estate investment trust's stock worth $76,000 after acquiring an additional 642 shares during the period. Diversify Advisory Services LLC lifted its position in Sabra Healthcare REIT by 5.7% during the 1st quarter. Diversify Advisory Services LLC now owns 12,878 shares of the real estate investment trust's stock worth $226,000 after acquiring an additional 689 shares during the period. Finally, IFP Advisors Inc lifted its position in Sabra Healthcare REIT by 16.2% during the 1st quarter. IFP Advisors Inc now owns 5,060 shares of the real estate investment trust's stock worth $88,000 after acquiring an additional 706 shares during the period. 99.40% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several analysts have recently commented on SBRA shares. BMO Capital Markets raised their price target on Sabra Healthcare REIT from $19.00 to $22.00 and gave the company a "market perform" rating in a report on Monday, August 25th. Truist Financial raised their price target on Sabra Healthcare REIT from $18.00 to $20.00 and gave the company a "hold" rating in a report on Tuesday, September 2nd. Scotiabank raised their price target on Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a report on Monday, June 23rd. Wells Fargo & Company raised their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an "overweight" rating in a report on Wednesday, August 27th. Finally, JMP Securities raised their price target on Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a "market outperform" rating in a report on Wednesday, August 6th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, Sabra Healthcare REIT currently has a consensus rating of "Moderate Buy" and an average price target of $20.83.
View Our Latest Research Report on SBRA
Sabra Healthcare REIT Trading Down 0.4%
Shares of NASDAQ:SBRA traded down $0.08 during midday trading on Friday, reaching $19.05. The company's stock had a trading volume of 1,519,531 shares, compared to its average volume of 2,188,764. The firm has a market cap of $4.57 billion, a price-to-earnings ratio of 25.07, a price-to-earnings-growth ratio of 1.53 and a beta of 0.88. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91. Sabra Healthcare REIT, Inc. has a 1 year low of $15.60 and a 1 year high of $20.03. The business has a 50 day moving average price of $18.68 and a 200 day moving average price of $17.98.
Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last announced its quarterly earnings data on Monday, August 4th. The real estate investment trust reported $0.38 EPS for the quarter, beating analysts' consensus estimates of $0.36 by $0.02. The business had revenue of $189.15 million during the quarter, compared to the consensus estimate of $185.64 million. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The business's revenue for the quarter was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.36 earnings per share. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. Research analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.
Sabra Healthcare REIT Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Friday, August 15th were issued a $0.30 dividend. The ex-dividend date was Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a yield of 6.3%. Sabra Healthcare REIT's dividend payout ratio (DPR) is presently 157.89%.
Sabra Healthcare REIT Profile
(
Free Report)
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
Read More

Before you consider Sabra Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Healthcare REIT wasn't on the list.
While Sabra Healthcare REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.